COM:SAMSUNGBIOLOGICS
Samsung Biologics
- Stock
Last Close
932K
22/11 06:30
Market Cap
58.01T
Beta: -
Volume Today
79.87K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 96.79B - | 141.70B 46.40% | 187.10B 32.04% | 256.17B 36.92% | 377.42B 47.33% | 549.22B 45.52% | 829.42B 51.02% | 1.69T 104.28% | 1.19T 29.89% | ||
average payables | 657.69M - | 939.72M 42.88% | 8.00B 751.35% | 7.82B 2.22% | 6.73B 14.00% | 33.64B 399.98% | 43.62B 29.67% | 45.93B 5.31% | 29.81B 35.11% | ||
average receivables | 42.66B - | 59.87B 40.36% | 55.45B 7.39% | 88.53B 59.66% | 180.30B 103.67% | 233.60B 29.56% | 346.10B 48.16% | 663.58B 91.73% | 444.15B 33.07% | ||
book value per share | 34.69K - | 55.52K 60.06% | 71.16K 28.17% | 59.48K 16.41% | 62.14K 4.47% | 65.13K 4.80% | 68.77K 5.60% | 74.65K 8.54% | 128.82K 72.57% | ||
capex per share | -33.45K - | -7.86K 76.49% | -2.93K 62.72% | -7.55K 157.59% | -4.25K 43.67% | -2.71K 36.29% | -2.22K 18.02% | -6.30K 183.50% | -14.47K 129.73% | ||
capex to depreciation | -21.89 - | -9.44 56.87% | -2.80 70.38% | -7.22 158.20% | -3.11 56.91% | -1.36 56.16% | -1.03 24.17% | -2.60 151.76% | -3.27 25.77% | ||
capex to operating cash flow | 5.33 - | 1.48 72.21% | 2.68 81.33% | -3.37 225.55% | 8.77 360.42% | -17.85 303.37% | -0.74 95.88% | -0.93 26.02% | -1.06 14.30% | ||
capex to revenue | -5.49 - | -4.31 21.51% | -0.57 86.74% | -1.09 90.34% | -0.53 51.14% | -0.26 51.35% | -0.13 50.61% | -0.27 110.58% | -0.34 25.20% | ||
cash per share | 5.58K - | 690.50 87.63% | 21.21K 2,971.33% | 5.69K 73.15% | 16.88K 196.36% | 10.32K 38.86% | 12.74K 23.48% | 20.51K 60.97% | 45.79K 123.23% | ||
days of inventory on hand | 217.48 - | 378.97 74.25% | 223.58 41.00% | 230.28 3.00% | 282.51 22.68% | 324.09 14.72% | 314.91 2.83% | 439.30 39.50% | 565.73 28.78% | ||
days payables outstanding | 2.80 - | 1.14 59.29% | 2.07 81.82% | 15.88 666.69% | 1.09 93.14% | 8.80 708.29% | 26.81 204.51% | 13.99 47.82% | 14.20 1.49% | ||
days sales outstanding | 160.20 - | 156.62 2.23% | 99.83 36.26% | 23.81 76.14% | 99.96 319.75% | 111.26 11.31% | 79.39 28.65% | 102.16 28.69% | 108.03 5.75% | ||
debt to assets | 0.35 - | 0.12 66.92% | 0.11 3.59% | 0.08 32.09% | 0.15 92.01% | 0.11 24.22% | 0.12 10.49% | 0.16 32.76% | 0.15 6.53% | ||
debt to equity | 0.80 - | 0.25 68.65% | 0.21 17.18% | 0.14 33.52% | 0.21 52.97% | 0.15 28.52% | 0.17 13.69% | 0.26 51.75% | 0.28 8.03% | ||
dividend yield | |||||||||||
earnings yield | -0.03 - | 0.24 785.29% | -0.02 108.65% | -0.00 81.75% | 0.01 340.61% | 0.01 21.79% | 0.00 37.75% | 0.01 49.42% | 0.01 113.79% | ||
enterprise value | 3.16T - | 8.73T 175.85% | 9.28T 6.26% | 26.23T 182.75% | 25.86T 1.38% | 29.48T 13.97% | 55.99T 89.93% | 61.62T 10.06% | 58.89T 4.44% | ||
enterprise value over ebitda | -45.18 - | 2.01 104.44% | -95.17 4,846.21% | 1.40K 1,572.75% | 62.98 95.51% | 94.03 49.31% | 129.86 38.10% | 83.20 35.93% | 42.89 48.45% | ||
ev to operating cash flow | -29.22 - | -32.88 12.52% | -148.02 350.25% | 175.05 218.26% | -797.86 555.78% | 2.90K 463.88% | 277.05 90.46% | 135.55 51.07% | 61.79 54.42% | ||
ev to sales | 30.09 - | 95.63 217.77% | 31.48 67.08% | 56.44 79.29% | 48.27 14.48% | 42.02 12.96% | 48.07 14.40% | 39.30 18.24% | 19.62 50.08% | ||
free cash flow per share | -39.73K - | -13.18K 66.84% | -4.02K 69.46% | -5.31K 31.97% | -4.74K 10.76% | -2.56K 46.01% | 800.44 131.29% | 500.19 37.51% | -805.45 261.03% | ||
free cash flow yield | -0.25 - | -0.08 66.84% | -0.03 67.34% | -0.01 48.84% | -0.01 7.06% | -0.01 53.37% | 0.00 116.40% | 0.00 42.84% | -0.00 277.11% | ||
graham net net | -32.29K - | -61.27K 89.73% | -36.46K 40.50% | -40.36K 10.71% | -6.51K 83.88% | -7.19K 10.47% | -6.88K 4.22% | -11.54K 67.67% | -36.56K 216.69% | ||
graham number | 65.89K - | 218.21K 231.19% | 70.25K 67.81% | 44.06K 37.28% | 68.45K 55.36% | 66.69K 2.58% | 74.68K 11.98% | 99.43K 33.15% | 182.11K 83.15% | ||
income quality | 1.09 - | -0.14 112.83% | 0.35 354.25% | -1.54 535.97% | -0.14 90.64% | 0.05 134.59% | 0.84 1,575.88% | 1.16 37.72% | 1.19 3.39% | ||
intangibles to total assets | 0.23 - | 0.00 98.96% | 0.00 22.21% | 0.00 41.87% | 0.00 26.32% | 0.00 10.51% | 0.00 1.58% | 0.00 11.08% | 0.36 8,806.13% | 0 100% | |
interest coverage | -48.40 - | -76.83 58.74% | -1.58 97.94% | 11.61 834.66% | 3.52 69.72% | 7.05 100.58% | 18.20 158.13% | 36.53 100.72% | 15.35 57.97% | ||
interest debt per share | 27.73K - | 13.90K 49.89% | 15.03K 8.16% | 8.25K 45.11% | 13.29K 61.04% | 10.16K 23.53% | 11.98K 17.90% | 19.55K 63.24% | 36.96K 89.03% | ||
inventory turnover | 1.68 - | 0.96 42.61% | 1.63 69.50% | 1.59 2.91% | 1.29 18.49% | 1.13 12.83% | 1.16 2.91% | 0.83 28.32% | 0.65 22.35% | ||
invested capital | 0.80 - | 0.25 68.65% | 0.21 17.18% | 0.14 33.52% | 0.21 52.97% | 0.15 28.52% | 0.17 13.69% | 0.26 51.75% | 0.28 8.03% | ||
market cap | 2.78T - | 8.07T 189.83% | 8.66T 7.32% | 26.04T 200.58% | 25.01T 3.95% | 28.95T 15.76% | 55.23T 90.79% | 60.38T 9.31% | 57.26T 5.16% | ||
net current asset value | -508.13B - | -2.99T 488.99% | -1.99T 33.53% | -2.59T 29.98% | -247.26B 90.44% | -200.91B 18.74% | -74.07B 63.13% | -155.73B 110.25% | -1.14T 631.97% | ||
net debt to ebitda | -5.42 - | 0.15 102.79% | -6.29 4,263.13% | 10.04 259.67% | 2.08 79.26% | 1.69 19.01% | 1.75 4.00% | 1.68 4.12% | 1.18 29.69% | ||
net income per share | -5.56K - | 38.12K 785.29% | -3.08K 108.09% | -1.45K 52.94% | 3.35K 331.04% | 3.03K 9.45% | 3.60K 18.75% | 5.89K 63.34% | 11.44K 94.38% | ||
operating cash flow per share | -6.28K - | -5.31K 15.41% | -1.09K 79.44% | 2.24K 305.18% | -484.78 121.63% | 151.87 131.33% | 3.02K 1,890.08% | 6.80K 124.96% | 13.66K 100.98% | ||
payables turnover | 130.46 - | 320.43 145.62% | 176.23 45.00% | 22.99 86.96% | 335.15 1,358.04% | 41.46 87.63% | 13.62 67.16% | 26.09 91.63% | 25.71 1.47% | ||
receivables turnover | 2.28 - | 2.33 2.28% | 3.66 56.89% | 15.33 319.18% | 3.65 76.18% | 3.28 10.16% | 4.60 40.16% | 3.57 22.29% | 3.38 5.43% | ||
research and ddevelopement to revenue | 0.00 - | 0.00 - | 0.02 - | ||||||||
return on tangible assets | -0.09 - | 0.32 448.55% | -0.02 107.34% | -0.01 42.44% | 0.04 377.78% | 0.03 8.38% | 0.04 9.28% | 0.05 31.71% | 0.08 51.54% | 0.05 28.87% | |
revenue per share | 6.10K - | 1.83K 70.05% | 5.14K 181.20% | 6.95K 35.34% | 8.01K 15.28% | 10.49K 30.96% | 17.42K 66.00% | 23.45K 34.63% | 43.03K 83.49% | ||
roe | -0.16 - | 0.69 528.14% | -0.04 106.31% | -0.02 43.70% | 0.05 321.15% | 0.05 13.60% | 0.05 12.45% | 0.08 50.49% | 0.09 12.64% | 0.09 1.78% | |
roic | -0.13 - | -0.04 66.17% | -0.00 89.48% | 0.01 357.86% | 0.01 32.84% | 0.05 472.94% | 0.05 4.55% | 0.06 21.86% | 0.07 9.27% | 0.09 32.80% | |
sales general and administrative to revenue | 0.20 - | 0.31 60.04% | 0.05 83.70% | 0.03 32.32% | 0.03 2.31% | 0.03 8.62% | 0.02 31.05% | 0.02 0.26% | 0.04 78.75% | ||
shareholders equity per share | 34.69K - | 55.52K 60.06% | 71.16K 28.17% | 59.48K 16.41% | 62.14K 4.47% | 65.13K 4.80% | 68.77K 5.60% | 74.65K 8.54% | 128.82K 72.57% | ||
stock based compensation to revenue | |||||||||||
tangible asset value | 318.51B - | 2.76T 766.70% | 4.07T 47.37% | 3.96T 2.73% | 4.14T 4.50% | 4.33T 4.77% | 4.58T 5.60% | 4.96T 8.38% | 3.02T 39.04% | 16.05T 430.77% | |
tangible book value per share | 18.47K - | 55.23K 199.03% | 70.92K 28.39% | 59.20K 16.52% | 61.84K 4.47% | 64.80K 4.78% | 68.43K 5.59% | 74.17K 8.39% | 43.34K 41.56% | ||
working capital | -19.96B - | -1.72T 8,513.13% | -1.02T 40.94% | -1.67T 64.16% | 867.15B 152.04% | 665.76B 23.23% | 1.16T 74.55% | 1.72T 47.66% | 2.28T 32.65% |
All numbers in (except ratios and percentages)